The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers
Hao Wang, Lingling Chi, Fuqiang Yu, Hongling Dai, Xiaojie Si, Chao Gao, Zhengjie Wang, Limin Liu, Jiaxin Zheng, Yu Ke, Hong‐Min Liu, Qiurong Zhang
Topics & Concepts
MAPK/ERK pathwayKinaseCancer researchProtein kinase ASignal transductionExtracellularCancerChemistryMitogen-activated protein kinaseCancer cellPharmacologyCell biologyMedicineBiologyBiochemistryInternal medicineMelanoma and MAPK PathwaysCancer Mechanisms and TherapySynthesis and biological activity